ProfileGDS4718 / 229777_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 99% 99% 88% 99% 99% 98% 96% 99% 99% 99% 99% 99% 99% 98% 98% 99% 99% 98% 98% 95% 99% 99% 99% 99% 99% 98% 99% 99% 99% 98% 99% 98% 99% 99% 98% 99% 99% 99% 99% 26% 99% 99% 98% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]12.808299
GSM549102patient 115, normal, homogenized [OPG study]12.899299
GSM549104patient 119, normal, homogenized [OPG study]8.8660688
GSM549108patient 138, normal, homogenized [OPG study]12.974899
GSM549119patient 077, normal, homogenized [OPG study]12.938499
GSM549133patient 032, cancer, homogenized [OPG study]11.582298
GSM549139patient 042, cancer, homogenized [OPG study]10.557696
GSM549099patient 107, normal, homogenized [OPG study]12.632599
GSM549109patient 139, normal, homogenized [OPG study]13.121199
GSM549110patient 046, normal, homogenized [OPG study]12.968999
GSM549114patient 063, normal, homogenized [OPG study]12.827199
GSM549122patient 082, normal, homogenized [OPG study]13.066299
GSM549134patient 033, cancer, homogenized [OPG study]11.826499
GSM549136patient 036, cancer, homogenized [OPG study]11.150998
GSM549140patient 044, cancer, homogenized [OPG study]11.436498
GSM549111patient 047, normal, homogenized [OPG study]12.557899
GSM549113patient 057, normal, homogenized [OPG study]12.946399
GSM549132patient 031, cancer, homogenized [OPG study]11.279698
GSM549137patient 038, cancer, homogenized [OPG study]11.509898
GSM549142patient 047, cancer, homogenized [OPG study]9.8238695
GSM549100patient 110, normal, homogenized [OPG study]12.963299
GSM549107patient 135, normal, homogenized [OPG study]12.853299
GSM549115patient 068, normal, homogenized [OPG study]12.97899
GSM549116patient 072, normal, homogenized [OPG study]12.784399
GSM549120patient 078, normal, homogenized [OPG study]12.459599
GSM549131patient 030, cancer, homogenized [OPG study]11.529898
GSM549118patient 074, normal, homogenized [OPG study]13.039699
GSM549129patient 027, cancer, homogenized [OPG study]11.484999
GSM549123patient 088, normal, homogenized [OPG study]12.833199
GSM549124patient 006, cancer, homogenized [OPG study]11.198498
GSM549126patient 015, cancer, homogenized [OPG study]12.587999
GSM549128patient 025, cancer, homogenized [OPG study]11.522998
GSM549103patient 117, normal, homogenized [OPG study]12.995899
GSM549117patient 073, normal, homogenized [OPG study]12.836399
GSM549138patient 041, cancer, homogenized [OPG study]11.505598
GSM549141patient 045, cancer, homogenized [OPG study]11.82599
GSM549130patient 028, cancer, homogenized [OPG study]11.565199
GSM549101patient 111, normal, homogenized [OPG study]12.780599
GSM549105patient 128, normal, homogenized [OPG study]12.812499
GSM549106patient 134, normal, homogenized [OPG study]4.3447626
GSM549112patient 048, normal, homogenized [OPG study]12.680499
GSM549125patient 011, cancer, homogenized [OPG study]12.214299
GSM549127patient 024, cancer, homogenized [OPG study]11.181198
GSM549135patient 035, cancer, homogenized [OPG study]10.954297